Erwin L. Robin

2.2k citations
37 papers · 1.8k · 2 hit papers · h-index 19

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology

Papers in

Erwin L. Robin

35 papers receiving 1.7k citations

Erwin L. Robin's Hit Papers

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer 2022 · 321 citations
3210+3+6Years since publication100200300400

Peers

Erwin L. Robin
Comparison fields: 5 of 87
  • Hematology 413
  • Oncology 612
  • Cancer Research 322
  • Genetics 147
  • Cardiology and Cardiovascular Medicine 240
Replace John H. Saiki with:
John H. Saiki United States
Reginald P. Pugh United States
Federico Calabresi Italy
E. George Elias United States
Ute Klinkhardt Germany
Süleyman Buyukberber Türkiye
Renate Thalhammer Austria
A N Békássy Sweden
Heinrich Bartels Germany
J L Francis United States
Erwin L. Robin relative to John H. Saiki United States John H. Saiki's profile →
Citations per field
00.5×20×40×59.5×
John H. Saiki · 1×
Citations per year

Countries citing papers authored by Erwin L. Robin

Since Specialization
Citations

This map shows the geographic impact of Erwin L. Robin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin L. Robin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin L. Robin more than expected).

Fields of papers citing papers by Erwin L. Robin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin L. Robin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin L. Robin. The network helps show where Erwin L. Robin may publish in the future.

Co-authors

The 25 scholars most cited alongside Erwin L. Robin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erwin L. Robin Line = papers co-authored together Erwin L. Robin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2017461
2
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Hit paper breakdown →
2022321
3 1996165
4 196791
5 200065
6
A paradigm shift in myelodysplastic syndromes.
199662
7 198749
8 197548
9 199747
10 197546
11 197036
12
Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
199933
13
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine.
199731
14 197426
15 201224
16 198224
17 199921
18 200620
19 198919
20 197018

About Erwin L. Robin

Erwin L. Robin is a scholar working on Hematology, Cardiology and Cardiovascular Medicine, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (6 papers), Cardiac Structural Anomalies and Repair (4 papers), Infective Endocarditis Diagnosis and Management (4 papers), Cardiovascular Function and Risk Factors (3 papers), Cancer Treatment and Pharmacology (3 papers), Streptococcal Infections and Treatments (3 papers) and Pericarditis and Cardiac Tamponade (2 papers). The work is most often cited by research in Hematology (413 citations), Oncology (612 citations), Cancer Research (322 citations), Genetics (147 citations) and Cardiology and Cardiovascular Medicine (240 citations). Erwin L. Robin has collaborated with scholars based in United States and Greece. Frequent co-authors include Azra Raza, Nora Goldschlager, Richard J. Bing, Saleem Dar, Sefer Gezer, Parameswaran Venugopal, Sairah Alvi, Stephanie J. Gregory, Agapi Parcharidou and Suneel Dinkar Mundle. Their work appears in journals such as The American Journal of Cardiology, Cancer, Leukemia Research, CHEST Journal and Congestive Heart Failure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact